CXCR 4 enhances cisplatin resistance of human tongue squamous cell carcinoma-Reference-Cited by-同舟云学术

CXCR 4 enhances cisplatin resistance of human tongue squamous cell carcinoma

Published:2018-12-16 Issue: Volume: Page:
ISSN:0904-2512
Container-title:Journal of Oral Pathology & Medicine
language:en
Short-container-title:J Oral Pathol Med

Author:

Zhuang Xiu‐Mei¹,Zhou Bin²

Affiliation:

1. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Sun Yat‐Sen Memorial Hospital Sun Yat‐Sen University Guangzhou 510120China

2. Department of Stomatology Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou 510120 China

Publisher

Wiley

Subject

Periodontics,Cancer Research,Otorhinolaryngology,Oral Surgery,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jop.12813

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ZMIZ1-Notch1 signaling axis for the treatment of tongue squamous cell carcinoma;Scientific Reports;2024-06-12

2. Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer;Archives of Oral Biology;2023-07

3. Prognostic Value of WNT1, NOTCH1, PDGFRβ, and CXCR4 in Oral Squamous Cell Carcinoma;Anticancer Research;2023-01-25

4. The upregulation of stromal antigen 3 expression suppresses the phenotypic hallmarks of hepatocellular carcinoma through the Smad3-CDK4/CDK6-cyclin D1 and CXCR4/RhoA pathways;BMC Gastroenterology;2022-08-08

5. Stem Cell Markers CXCR-4 and CD133 Predict Aggressive Phenotype and Their Double Positivity Indicates Poor Prognosis of Oral Squamous Cell Carcinoma;Cancers;2021-11-23